531
Views
1
CrossRef citations to date
0
Altmetric
Review Article

Recent advances in freeze-drying: variables, cycle optimization, and innovative techniques

ORCID Icon & ORCID Icon
Pages 904-923 | Received 23 Aug 2022, Accepted 25 Sep 2022, Published online: 18 Oct 2022

References

  • Abdelwahed W, Degobert G, Fessi H. 2006. Freeze-drying of nanocapsules: impact of annealing on the drying process. Int J Pharm. 324(1):74–82.
  • Abdelwahed W, Degobert G, Stainmesse S, Fessi H. 2006. Freeze-drying of nanoparticles: formulation, process and storage considerations. Adv Drug Deliv Rev. 58(15):1688–1713.
  • Abdul-Fattah AM, Kalonia DS, Pikal MJ. 2007. The challenge of drying method selection for protein pharmaceuticals: product quality Implications. J Pharm Sci. 96(8):1886–1916.
  • Adali, Merve B, Antonello A Barresi, Gianluca Boccardo, and Roberto Pisano. 2020. “Spray Freeze-Drying as a Solution to Continuous Manufacturing of Pharmaceutical Products in Bulk.” Processes. https://doi.org/10.3390/pr8060709.
  • Adams GDJ, Ramsay JR. 1996. Optimizing the lyophilization cycle and the consequences of collapse on the pharmaceutical acceptability of Erwinia L-asparaginase. J Pharm Sci. 85(12):1301–1305.
  • Allmendinger A, Butt YL, Mietzner R, Schmidt F, Luemkemann J, Martinez CL. 2020. Controlling ice nucleation during lyophilization: process optimization of vacuum-induced surface freezing. Processes. 8(10):1263.
  • Altmann R. 1894. Die Elementarorganismen und ihre Beziehungen zu den Zellen. Veitliepzing. 277:1–273.
  • Andia I, Perez-valle A, Amo C, Del Maffulli N. 2020. Freeze-drying of platelet-rich plasma: the quest for standardization. Int J Mol Sci. 21(18):6904–6920.
  • Assegehegn G, Brito-de la Fuente E, Franco JM, Gallegos C. 2019. The importance of understanding the freezing step and its impact on freeze-drying process performance. J Pharm Sci. 108(4):1378–1395.
  • Awotwe-Otoo D, Agarabi C, Read EK, Lute S, Brorson KA, Khan MA, Shah RB. 2013. Impact of controlled ice nucleation on process performance and quality attributes of a lyophilized monoclonal antibody. Int J Pharm. 450(1–2):70–78.
  • Awotwe-Otoo D, Agarabi C, Wu GK, Casey E, Read E, Lute S, Brorson KA, Khan MA, Shah RB. 2012. Quality by design: impact of formulation variables and their interactions on quality attributes of a lyophilized monoclonal antibody. Int J Pharm. 438(1–2):167–175.
  • Baheti A, Kumar L, Bansal AK. 2010. Excipients used in lyophilization of small molecules. J Excipients Food Chem. 1(1):41–54.
  • Bansal A, Lale S, Goyal M. 2011. Development of lyophilization cycle and effect of excipients on the stability of catalase during lyophilization. Int J Pharm Investig. 1(4):214–221.
  • Barresi A, Ghio S, Fissore D, Pisano R. 2009. Freeze drying of pharmaceutical excipients close to collapse temperature: influence of the process conditions on process time and product quality. Dry Technol. 27(6):805–816.
  • Beech KE, Biddlecombe JG, Van Der Walle CF, Stevens LA, Rigby SP, Burley JC, Allen S. 2015. Insights into the influence of the cooling profile on the reconstitution times of amorphous lyophilized protein formulations. Eur J Pharm Biopharm. 96:247–254.
  • Bell LN, Hageman MJ, Muraoka LM. 1995. Thermally induced denaturation of lyophilized bovine somatotropin and lysozyme as impacted by moisture and excipients. J Pharm Sci. 84(6):707–712.
  • Bexiga NM, Bloise AC, Alencar AM, Stephano MA. 2018. Freeze-drying of ovalbumin-loaded carboxymethyl chitosan nanocapsules: impact of freezing and annealing procedures on physicochemical properties of the formulation during dried storage. Dry Technol. 36(4):400–417.
  • Bisht D, Iqbal Z. 2018. Lyophilization - process and optimization for pharmaceuticals. Int J Drug Reg Affairs. 3(1):30–40.
  • Bjelošević M, Seljak KB, Trstenjak U, Logar M, Brus B, Ahlin Grabnar P. 2018. Aggressive conditions during primary drying as a contemporary approach to optimise freeze-drying cycles of biopharmaceuticals. Eur J Pharm Sci. 122:292–302.
  • Bjelošević M, Zvonar Pobirk A, Planinšek O, Ahlin Grabnar P. 2020. Excipients in freeze-dried biopharmaceuticals: contributions toward formulation stability and lyophilisation cycle optimisation. Int J Pharm. 576:119029.
  • Bullich R. 2013. Telstar industry session: continuous freeze drying. Presented at: Pharmaprocess forum. EuroDrying: Barcelona.
  • Cao W, Krishnan S, Ricci M p, Shih LY, Liu D, Gu J u, Jameel F. 2013. Rational design of lyophilized high concentration protein formulations-mitigating the challenge of slow reconstitution with multidisciplinary strategies. Eur J Pharm Biopharm. 85(2):287–293.
  • Capozzi LC, Trout BL, Pisano R. 2019. From batch to continuous: freeze-drying of suspended vials for pharmaceuticals in unit-doses. Ind Eng Chem Res. 58(4):1635–1649.
  • Carpenter JF, Chang BS, Garzon-Rodriguez W, Randolph TW. 2002. Rational design of stable lyophilized protein formulations: theory and practice. Pharm Biotechnol. 13:109–133.
  • Challener CA. 2017. For lyophilization, excipients really do matter. BioPharm Int. 30(1):32–35.
  • Chang BS, Randall CS. 1992. Use of subambient thermal analysis to optimize protein lyophilization. Cryobiology. 29(5):632–656.
  • Chang BS, Reeder G, Carpenter JF. 1996. Development of a stable freeze-dried formulation of recombinant human interleukin-1 receptor antagonist. Pharm Res. 13(2):243–249.
  • Chang LL, Shepherd D, Sun J, Ouellette D, Grant KL, Tang XC, Pikal MJ. 2005. Mechanism of protein stabilization by sugars during freeze-drying and storage: native structure preservation, specific interaction, and/or immobilization in a glassy matrix? J Pharm Sci. 94(7):1427–1444.
  • Chaudhari SP, Dugar RP. 2017. Application of surfactants in solid dispersion technology for improving solubility of poorly water soluble drugs. J Drug Deliv Sci Technol. 41:68–77.
  • Chung NO, Lee MK, Lee J. 2012. Mechanism of freeze-drying drug nanosuspensions. Int J Pharm. 437(1–2):42–50.
  • Cover JAWM. 2012. Method and system for freeze-drying injectable compositionin particular pharmaceutical compositions. US Patent US
  • Crowe JH, Leslie SB, Crowe LM. 1994. Is vitrification sufficient to preserve liposomes during freeze-drying? Cryobiology. 31(4):355–366.
  • da Silva Guedes J, Pimentel TC, Diniz-Silva HT, Tayse da Cruz Almeida E, Tavares JF, Leite de Souza E, Garcia EF, Magnani M. 2019. Protective effects of β-glucan extracted from spent brewer yeast during freeze-drying, storage and exposure to simulated gastrointestinal conditions of probiotic lactobacilli. LWT. 116:108496.
  • Dalvi-Isfahan M, Hamdami N, Xanthakis E, Le-Bail A. 2017. Review on the control of ice nucleation by ultrasound waves, electric and magnetic fields. J Food Eng. 195:222–234.
  • De Beer TRM, Vercruysse P, Burggraeve A, Quinten T, Ouyang J, Zhang X, Vervaet C, Remon JP, Baeyens WRG. 1 2009. In-line and real-time process monitoring of a freeze drying process using Raman and NIR spectroscopy as complementary Process Analytical Technology (PAT) tools. J Pharm Sci. 98(9):3430–3446.
  • Del Valle EMM. 2004. Cyclodextrins and their uses: a review. Process Biochem. 39(9):1033–1046.
  • Depaz RA, Pansare S, Patel SM. 2016. Freeze-drying above the glass transition temperature in amorphous protein formulations while maintaining product quality and improving process efficiency. J Pharm Sci. 105(1):40–49.
  • Eastoe J. 2005. Surfactant aggregation and adsorption at interfaces characteristic features of surfactants. In: Colloid science: principles, methods and applications. Hoboken (NJ): Wiley; p. 51–76.
  • Eliyahu S, Almeida A, Macedo MH, das Neves J, Sarmento B, Bianco-Peled H. 2020. The effect of freeze-drying on mucoadhesion and transport of acrylated chitosan nanoparticles. Int J Pharm. 573:118739.
  • Emami F, Vatanara A, Park EJ, Na DH. 2018. Drying technologies for the stability and bioavailability of biopharmaceuticals. Pharmaceutics. 10(3):131.
  • Fang R, Bogner RH, Nail SL, Pikal MJ. 2020. Stability of freeze-dried protein formulations: contributions of ice nucleation temperature and residence time in the freeze-concentrate. J Pharm Sci. 109(6):1896–1904.
  • Flosdorf EW, Mudd S. 1935. Procedure and apparatus for preservation in " lyophile " form of serum and other biological substances. J Immunol. 29:389–425.
  • Forney-Stevens KM, Bogner RH, Pikal MJ. 2016. Addition of amino acids to further stabilize lyophilized sucrose-based protein formulations: I. screening of 15 amino acids in two model proteins. J Pharm Sci. 105(2):697–704.
  • Franks F. 1992. Freeze-drying: from empiricism to predictability. The significance of glass transitions. Dev Biol Stand. 74:9–18.
  • Garcia-Amezquita LE, Welti-Chanes J, Vergara-Balderas FT, Bermúdez-Aguirre D. 2015. Freeze-drying: the basic process. In: Encyclopedia of food and health. Cambridge (MA): Academic Press; p. 104–109.
  • Garzon-Rodriguez W, Koval RL, Chongprasert S, Krishnan S, Randolph TW, Warne NW, Carpenter JF. 2004. Optimizing storage stability of lyophilized recombinant human interleukin-11 with disaccharide/hydroxyethyl starch mixtures. J Pharm Sci. 93(3):684–696.
  • Gervasi V, Dall Agnol R, Cullen S, McCoy T, Vucen S, Crean A. 2018. Parenteral protein formulations: an overview of approved products within the European Union. Eur J Pharm Biopharm. 131:8–24.
  • Guimarães D, Noro J, Silva C, Cavaco-Paulo A, Nogueira E. 2019. Protective effect of saccharides on freeze-dried liposomes encapsulating drugs. Front Bioeng Biotechnol. 7:424–428.
  • Hajare AA, More HN, Walekar PS, Hajare DA. 2012. Optimization of Freeze drying cycle protocol using real time microscopy and integrated differential thermal analysis-electrical impedance. Res J Pharm Technol. 5(7):985–991.
  • Horn J, Schanda J, Friess W. 2018. Impact of fast and conservative freeze-drying on product quality of protein-mannitol-sucrose-glycerol lyophilizates. Eur J Pharm Biopharm. 127:342–354.
  • Horn J, Tolardo E, Fissore D, Friess W. 2018. Crystallizing amino acids as bulking agents in freeze-drying. Eur J Pharm Biopharm. 132:70–82.
  • Hottot A, Nakagawa K, Andrieu J. 2008. Effect of ultrasound-controlled nucleation on structural and morphological properties of freeze-dried mannitol solutions. Chem Eng Res Des. 86(2):193–200.
  • Hozumi T, Saito A, Okawa S, Watanabe K. 2003. Effects of electrode materials on freezing of supercooled water in electric freeze control. Int J Refrig. 26(5):537–542.
  • Iurian S, Tomuta I, Bogdan C, Rus L, Tokes T, Barbu-Tudoran L, Achim M, Moldovan M, Leucuta S. 2016. Defining the design space for freeze-dried orodispersible tablets with meloxicam. Drug Dev Ind Pharm. 42(12):1977–1989.
  • Jain NK, Roy I. 2009. Effect of trehalose on protein structure. Protein Sci. 18(1):24–36.
  • Jiang S, Nail SL. 1998. Effect of process conditions on recovery of protein activity after freezing and freeze-drying. Eur J Pharm Biopharm. 45(3):249–257.
  • Kadji FMN, Kotani K, Tsukamoto H, Hiraoka Y, Hagiwara K. 2022. Stability of enveloped and nonenveloped viruses in hydrolyzed gelatin liquid formulation. Virol J. 19(1):1–17.
  • Kasper JC, Friess W. 2011. The freezing step in lyophilization: physico-chemical fundamentals, freezing methods and consequences on process performance and quality attributes of biopharmaceuticals. Eur J Pharm Biopharm. 78(2):248–263.
  • Kasraian K, DeLuca PP. 1995. Thermal analysis of the tertiary butyl Alcohol-water system and its implications on freeze-drying. Pharm Res an off J Am Assoc Pharm Sci. 12(4):484–490.
  • Kawasaki H, Shimanouchi T, Kimura Y. 2019. Recent development of optimization of lyophilization process. J Chem. 2019:1–14.
  • Kinoshita H, Orita S, Inage K, Fujimoto K, Shiga Y, Abe K, Inoue M, Norimoto M, Umimura T, Ishii T, et al. 2020. Freeze-dried platelet-rich plasma induces osteoblast proliferation via platelet-derived. Asian Spine J. 14(1):1–8.
  • Kramer M, Sennhenn B, Lee G. 2002. Freeze-drying using vacuum-induced surface freezing. J Pharm Sci. 91(2):433–443.
  • Kulkarni SS, Suryanarayanan R, Rinella JV, Bogner RH. 2018. Mechanisms by which crystalline mannitol improves the reconstitution time of high concentration lyophilized protein formulations. Eur J Pharm Biopharm. 131:70–81.
  • Kunz C, Schuldt-Lieb S, Gieseler H. 2018. Freeze-drying from organic cosolvent systems, part 1: thermal analysis of cosolvent-based placebo formulations in the frozen state. J Pharm Sci. 107(3):887–896.
  • Kuu WY, Doty MJ, Nisipeanu E, Rebbeck CL, Cho YK, Smit MH. 2014. Modeling of heat and mass transfer processes for the gap-lyophilization system using the mannitol–trehalose–NaCl formulation. J Pharm Sci. 103(9):2784–2796.
  • Kuu WY, Doty MJ, Rebbeck CL, Hurst WS, Cho YK. 2013. Gap-freezing approach for shortening the lyophilization cycle time of pharmaceutical formulations—demonstration of the concept. J Pharm Sci. 102(8):2572–2588.
  • Langford A, Bhatnagar B, Walters R, Tchessalov S, Ohtake S. 2018. Drying technologies for biopharmaceutical applications: recent developments and future direction. Dry Technol. 36(6):677–684.
  • Larsen BS, Skytte J, Svagan AJ, Meng-Lund H, Grohganz H, Löbmann K. 2019. Using dextran of different molecular weights to achieve faster freeze-drying and improved storage stability of lactate dehydrogenase. Pharm Dev Technol. 24(3):323–328.
  • Levine H. 1988. Principles of cryostabilization technology from structure/property relationships of water-doluble food carbohydrates - a review. Cryo Lett. 9:21–36.
  • Leys L, Vanbillemont B, Van Bockstal PJ, Lammens J, Nuytten G, Corver J, Vervaet C, De Beer T. 2020. A primary drying model-based comparison of conventional batch freeze-drying to continuous spin-freeze-drying for unit doses. Eur J Pharm Biopharm. 157:97–107.
  • Li X, Thakkar SG, Ruwona TB, et al. 2016. A method of lyophilizing vaccines containing aluminum salts into a dry powder without causing particle aggregation or decreasing the immunogenicity following reconstitution. J Control Release. 204:38–50.
  • Liu J, Viverette T, Virgin M, Anderson M, Dalal P. 2005. A study of the impact of freezing on the lyophilization of a concentrated formulation with a high fill depth. Pharm Dev Technol. 10(2):261–272.
  • Liu J. 2006. Physical characterization of pharmaceutical formulations in frozen and freeze-dried solid states: techniques and applications in freeze-drying development. Pharm Dev Technol. 11(1):3–28.
  • Luoma J, Ingham E, Martinez CL, Allmendinger A. 2020. Comparison of techniques to control ice nucleation during lyophilization. Processes. 8(11):1439.
  • Malik KP, Duru C, Ahmed M, Matejtschuk P. 2010. Analytical options for the measurement of residual moisture content in lyophilized biological materials. Am Pharm Rev. 13:42–47.
  • Mattern M, Winter G, Kohnert U, Lee G. 1999. Formulation of proteins in vacuum-dried glasses. II. Process and storage stability in sugar-free amino acid systems. Pharm Dev Technol. 4(2):199–208.
  • Medi MB, Chintala R, Bhambhani A. 2014. Excipient selection in biologics and vaccines formulation development. Eur Pharm Rev. 19(1):16–20.
  • Mehanna MM, Abla KK, Domiati S, Elmaradny H. 2022. Superiority of microemulsion-based hydrogel for non-steroidal anti-inflammatory drug transdermal delivery: a comparative safety and anti-nociceptive efficacy study. Int J Pharm. 622:121830.
  • Mehanna MM, Abla KK, Elmaradny HA. 2021. Tailored limonene-based nanosized microemulsion: formulation, physicochemical characterization and in-vivo Skin irritation assessment. Adv Pharm Bull. 11(2):274–285.
  • Mehmood Y, Farooq U. 2015. Excipients use in parenteral and lyophilized formulation development. Open Sci J Pharm Pharmacol. 3(3):19–27.
  • Mensink MA, Frijlink HW, van der Voort Maarschalk K, Hinrichs WLJ. 2017. How sugars protect proteins in the solid state and during drying (review): mechanisms of stabilization in relation to stress conditions. Eur J Pharm Biopharm. 114:288–295.
  • Merivaara A, Zini J, Koivunotko E, Valkonen S, Korhonen O, Fernandes FM, Yliperttula M. 2021. Preservation of biomaterials and cells by freeze-drying: change of paradigm. J Control Release. 10(336):480–498.
  • Meryman HT. 1976. Historical recollections of freeze-drying. Dev Biol Stand. 36:29–32.
  • Meyer JD, Nayar R, Manning MC. 2009. Impact of bulking agents on the stability of a lyophilized monoclonal antibody. Eur J Pharm Sci. 38(1):29–38.
  • Millqvist-Fureby A, Malmsten M, Bergenstâhl B. 1999. Surface characterisation of freeze-dried protein/carbohydrate mixtures. Int J Pharm. 191(2):103–114.
  • Molnar A, Lakat T, Hosszu A, Szebeni B, Balogh A, Orfi L, Szabo AJ, Fekete A, Hodrea J. 2021. Lyophilization and homogenization of biological samples improves reproducibility and reduces standard deviation in molecular biology techniques. Amino Acids. 53(6):917–928.
  • Mourya VK, Choudhari Y, Padame M. 2016. Quality by design: impact of product variables and their interaction on the particle size in lyophilization of sodium fluoride. Soft Nanosci Lett. 06(01):1–10.
  • Muhoza B, Xia S, Wang X, Zhang X. 2020. The protection effect of trehalose on the multinuclear microcapsules based on gelatin and high methyl pectin coacervate during freeze-drying. Food Hydrocoll. 105:105807.
  • Nalini T, Basha SK, Mohamed Sadiq AM, Kumari VS, Kaviyarasu K. 2019. Development and characterization of alginate/chitosan nanoparticulate system for hydrophobic drug encapsulation. J Drug Deliv Sci Technol. 52:65–72.
  • Ni N, Tesconi M, Tabibi SE, Gupta S, Yalkowsky SH. 2001. Use of pure t-butanol as a solvent for freeze-drying: a case study. Int J Pharm. 226(1–2):39–46.
  • Nuytten G, Revatta SR, Van Bockstal PJ, Kumar A, Lammens J, Leys L, Vanbillemont B, Corver J, Vervaet C, De Beer T. 2021. Development and application of a mechanistic cooling and freezing model of the spin freezing step within the framework of continuous freeze-drying. Pharmaceutics. 13(12):2076.
  • Oddone I, Barresi AA, Pisano R. 2017. Influence of controlled ice nucleation on the freeze-drying of pharmaceutical products: the secondary drying step. Int J Pharm. 524(1–2):134–140.
  • Oddone I, Van Bockstal PJ, De Beer T, Pisano R. 2016. Impact of vacuum-induced surface freezing on inter- and intra-vial heterogeneity. Eur J Pharm Biopharm. 103:167–178.
  • Ohtake S, Kita Y, Arakawa T. 2011. Interactions of formulation excipients with proteins in solution and in the dried state. Adv Drug Deliv Rev. 63(13):1053–1073.
  • Oyinloye TM, Yoon WB. 2020. Effect of freeze-drying on quality and grinding process of food produce: a review. Processes. 8(3):354.
  • Paik SH, Kim YJ, Han SK, Kim JM, Huh JW, Park YI. 2012. Mixture of three amino acids as stabilizers replacing albumin in lyophilization of new third generation recombinant factor VIII GreenGene F. Biotechnol Prog. 28(6):1517–1525.
  • Parhi R, Suresh P. 2013. Supercritical fluid technology: a review. JAPST. 1(1):13–36.
  • Passot S, Tréléa IC, Marin M, Galan M, Morris GJ, Fonseca F. 2009. Effect of controlled ice nucleation on primary drying stage and protein recovery in vials cooled in a modified freeze-dryer. J Biomech Eng. 131(7):1–5.
  • Patel SM, Doen T, Pikal MJ. 2010. Determination of end point of primary drying in freeze-drying process control. AAPS PharmSciTech. 11(1):73–84.
  • Patel SM, Pikal M. 2009. Process analytical technologies (PAT) in freeze-drying of parenteral products. Pharm Dev Technol. 14(6):567–587.
  • Patel SM, Pikal MJ. 2011. Emerging freeze-drying process development and scale-up issues. AAPS PharmSciTech. 12(1):372–378.
  • Petersen A, Rau G, Glasmacher B. 2006. Reduction of primary freeze-drying time by electric field induced ice nucleus formation. Heat Mass Transfer. 42(10):929–938.
  • Petzold G, Aguilera JM. 2009. Ice morphology: fundamentals and technological applications in foods. Food Biophys. 4(4):378–396.
  • Pisano R, Arsiccio A, Capozzi LC, Trout BL. 2019. Achieving continuous manufacturing in lyophilization: technologies and approaches. Eur J Pharm Biopharm. 142:265–279.
  • Pisano R, Fissore D, Barresi AA. 2012. Quality by design in the secondary drying step of a freeze-drying process. Dry Technol. 30(11–12):1307–1316.
  • Pisano R. 2022. Automatic control of a freeze-drying process: detection of the end point of primary drying. Dry Technol. 40(1):140–157.
  • Pramanick S, Singodia D, Chandel V. 2013. Excipient selection in parenteral formulation development. Pharma Times. 45(3):65–77.
  • Pyne A, Surana R, Suryanarayanan R. 2002. Crystallization of mannitol below Tg′ during freeze-drying in binary and ternary aqueous systems. Pharm Res. 19(6):901–908.
  • Pyne A, Suryanarayanan R. 2001. Phase transitions of glycine in frozen aqueous solutions and during freeze-drying. Pharm Res. 18(10):1448–1454.
  • Ramyasree J, Hindustan AA, Chinthaguinjala H, Reshma TC, Venkata HVY, Bharath K. 2020. Solubility enhancement of drugs with aid of surfactants: research done since last two decades. Int J Pharma Bio Sci. 10(5):11–16.
  • Randolph TW, Webb SD, Cleland JL, Carpenter JF. 2002. A new mechanism for decreasing aggregation of recombinant human interferon-γ by a surfactant: slowed dissolution of lyophilized formulations in a solution containing 0.03% Polysorbate 20. J Pharm Sci. 91(2):543–558.
  • Ray L, May JC. 2010. Glimpses into the realm of freeze-drying: classical issues and new ventures. In: Freeze-drying/lyophilization of pharmaceutical and biological products. Boca Raton (FL): CRC Press; p. 10545.
  • Rayaprolu BM, Strawser JJ, Anyarambhatla G. 2018. Excipients in parenteral formulations: selection considerations and effective utilization with small molecules and biologics. Drug Dev Ind Pharm. 44(10):1565–1571.
  • Remmele R, Krishnan SJ, Callahan W. 2012. Development of stable lyophilized protein drug products. Curr Pharm Biotechnol. 13(3):471–496.
  • Renteria Gamiz AG, Van Bockstal PJ, De Meester S, De Beer T, Corver J, Dewulf J. 2019. Analysis of a pharmaceutical batch freeze dryer: resource consumption, hotspots, and factors for potential improvement. Dry Technol. 37(12):1563–1582.
  • Ressing ME, Jiskoot W, Talsma H, Ingen CW, van Beuvery EC, Crommelin DJA. 1992. The influence of sucrose, dextran, and hydroxypropyl-β-cyclodextrin as lyoprotectants for a freeze-dried mouse IgG2a monoclonal antibody (MN12). Pharm Res. 9(2):266–270.
  • Rochelle do Vale Morais Morais A, Xavier FH, Jr do Nascimento Alencar É, Melo de Oliveira C, Dantas Santos N, Antônio Silva-Júnior A, Barratt G, Sócrates Tabosa do Egito E. 2019. Optimization of the freeze-drying process for microemulsion systems. Dry Technol. 37(14):1745–1756.
  • Romyasamit C, Saengsuwan P, Boonserm P, Thamjarongwong B, Singkhamanan K. 2022. Optimization of cryoprotectants for freeze-dried potential probiotic Enterococcus faecalis and evaluation of its storage stability. Dry Technol. 40(11):2283–2292.
  • Sadikoglu H, Ozdemir M, Seker M. 2006. Freeze-drying of pharmaceutical products: research and development needs. Dry Technol. 24(7):849–861.
  • Sahoo SK, Panyam J, Prabha S, Labhasetwar V. 2002. Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J Control Release. 82(1):105–114.
  • Sarciaux JM, Mansour S, Hageman MJ, Nail SL. 1999. Effects of buffer composition and processing conditions on aggregation of bovine IgG during freeze-drying. J Pharm Sci. 88(12):1354–1361.
  • Schwarz C, Mehnert W. 1997. Freeze-drying of drug-free and drug-loaded solid lipid nanoparticles (SLN). Int J Pharm. 157(2):171–179.
  • Searles JA, Carpenter JF, Randolph TW. 2001a. The ice nucleation temperature determines the primary drying rate of lyophilization for samples frozen on a temperature-controlled shelf. J Pharm Sci. 90(7):860–871.
  • Searles JA, Carpenter JF, Randolph TW. 2001b. Annealing to optimize the primary drying rate, reduce freezing-induced drying rate heterogeneity, and determine T(g)’ in pharmaceutical lyophilization. J Pharm Sci. 90(7):872–887.
  • Serno T, Geidobler R, Winter G. 2011. Protein stabilization by cyclodextrins in the liquid and dried state. Adv Drug Deliv Rev. 63(13):1086–1106.
  • Shamblin SL, Huang EY, Zografi G. 1996. The effects of co-lyophilized polymeric additives on the glass transition temperature and crystallization of amorphous sucrose. J Therm Anal. 47(5):1567–1579.
  • Singh SN, Kumar S, Bondar V, Wang N, Forcino R, Colandene J, Nesta D. 2018. Unexplored benefits of controlled ice nucleation: lyophilization of a highly concentrated monoclonal antibody solution. Int J Pharm. 552(1–2):171–179.
  • Stärtzel P. 2018. Arginine as an excipient for protein freeze-drying: a mini review. J Pharm Sci. 107(4):960–967.
  • Steffen C, Tokplonou E, Jaillard P, Dia R, Alladji MNDB, Gessner B. 2014. A field based evaluation of adverse events following menafrivac® vaccine delivered in a controlled temperature chain (CTC) approach in Benin. Pan Afr Med J. 18:1–14.
  • Takeuchi H, Yamamoto H, Toyoda T, Toyobuku H, Hino T, Kawashima Y. 1998. Physical stability of size controlled small unilameller liposomes coated with a modified polyvinyl alcohol. Int J Pharm. 164(1–2):103–111.
  • Tang X, Pikal MJ. 2004. Design of freeze-drying processes for pharmaceuticals: practical advice. Pharm Res. 21(2):191–200.
  • Teagarden DL, Baker DS. 2002. Practical aspects of lyophilization using non-aqueous co-solvent systems. Eur J Pharm Sci. 15(2):115–133.
  • Tomba E, Facco P, Bezzo F, Barolo M. 2013. Latent variable modeling to assist the implementation of Quality-by-Design paradigms in pharmaceutical development and manufacturing: a review. Int J Pharm. 457(1):283–297.
  • Trenkenschuh E, Friess W. 2021. Freeze-drying of nanoparticles: how to overcome colloidal instability by formulation and process optimization. Eur J Pharm Biopharm. 165:345–360.
  • Ullrich S, Seyferth S, Lee G. 2015. Measurement of shrinkage and cracking in lyophilized amorphous cakes. Part IV: effects of freezing protocol. Int J Pharm. 495(1):52–57.
  • Umerska A, Paluch KJ, Santos-Martinez MJ, Corrigan OI, Medina C, Tajber L. 2018. Freeze drying of polyelectrolyte complex nanoparticles: effect of nanoparticle composition and cryoprotectant selection. Int J Pharm. 552(1–2):27–38.
  • Van Bockstal PJ, Corver J, Mortier STFC, De Meyer L, Nopens I, Gernaey KV, De Beer T. 2018. Developing a framework to model the primary drying step of a continuous freeze-drying process based on infrared radiation. Eur J Pharm Biopharm. 127:159–170.
  • Farkas Istvan. 2017. Papers from the 5th European Drying Conference (EuroDrying 2015). Drying Technology. 35(8):905.
  • Vanbillemont B, Nicolaï N, Leys L, De Beer T. 2020. Model-based optimisation and control strategy for the primary drying phase of a lyophilisation process. Pharmaceutics. 12(2):181.
  • Verlhac P, Vessot-Crastes S, Degobert G, Cogné C, Andrieu J, Beney L, Gervais P, Moundanga S. 2020. Experimental study and optimization of freeze-drying cycles of a model Casei type probiotic bacteria. Dry Technol. 38(16):2120–2133.
  • Vessot S, Andrieu J. 2012. A Review on freeze drying of drugs with tert-butanol (TBA) + water systems: characteristics, advantages, drawbacks. Dry Technol. 30(4):377–385.
  • Wan Y, Hickey JM, Bird C, Witham K, Fahey P, Forster A, Joshi SB, Volkin DB. 2018. Development of stabilizing formulations of a trivalent inactivated poliovirus vaccine in a dried state for delivery in the nanopatchTM microprojection array. J Pharm Sci. 107(6):1540–1551.
  • Wang L, Ma Y, Gu Y, Liu Y, Zhao J, Yan B, Wang Y. 2018. Cryoprotectant choice and analyses of freeze-drying drug suspension of nanoparticles with functional stabilisers. J Microencapsul. 35(3):241–248.
  • Wang W. 2000. Lyophilization and development of solid protein pharmaceuticals. Int J Pharma. 203(1–2):1–60.
  • Wang Y, Grainger DW. 2019. Lyophilized liposome-based parenteral drug development: reviewing complex product design strategies and current regulatory environments. Adv Drug Deliv Rev. 151–152:56–71.
  • Weisselberg E. 2010. Apparathus and method for continuous lyophilization. US Patent US 8528225.
  • Wu C, Shamblin S, Varshney D, Shalaev E. 2015. Advance understanding of buffer behavior during lyophilization. Lyophilized Biol Vaccin. 25–41.
  • Yong CS, Choi JS, Quan QZ, Rhee JD, Kim CK, Lim SJ, Kim KM, Oh PS, Choi HG. 2001. Effect of sodium chloride on the gelation temperature, gel strength and bioadhesive force of poloxamer gels containing diclofenac sodium. Int J Pharm. 226(1–2):195–205.
  • Zambaux MF, Bonneaux F, Gref R, Maincent P, Dellacherie E, Alonso MJ, Labrude P, Vigneron C. 1998. Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method. J Control Release. 50(1–3):31–40.
  • Zheng B, Zheng B, Carr AJ, Yu X, McClements DJ, Bhatia SR. 2020. Emulsions stabilized by inorganic nanoclays and surfactants: stability, viscosity, and implications for applications. Inorg Chim Acta. 508:119566.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.